Literature DB >> 16427905

Early postoperative anticoagulation after mechanical valve replacement: a systematic review.

Alexander Kulik1, Fraser D Rubens, Philip S Wells, Clive Kearon, Thierry G Mesana, Judith van Berkom, B-Khanh Lam.   

Abstract

The optimal approach to early postoperative anticoagulation after mechanical valve implantation remains controversial. This review article examines the pathogenesis of thrombus formation and the different strategies for early postoperative anticoagulation. The most commonly reported anticoagulation regimens had the after estimates of early postoperative thromboembolism and hemorrhage: oral anticoagulation alone (0.9%, 3.3%); oral anticoagulation with intravenous unfractionated heparin (1.1%, 7.2%); and oral anticoagulation with low molecular weight heparin (0.6%, 4.8%). Although intravenous heparin may be associated with a higher incidence of hemorrhage, a randomized trial is needed to provide the best evidence regarding early postoperative anticoagulation after mechanical valve implantation. Nearly four decades have passed since the first mechanical prosthetic valves were implanted. Frequent thromboembolic complications with the first mechanical valves led to recommendations of universal anticoagulation for these patients. Since then, several design changes and modifications have been made to improve the longevity, hemodynamics, and thrombogenicity of newer generation mechanical valves. With improved blood flow, less stasis, and less thrombogenic materials, lower rates of thromboembolism have been reported. Despite these advances however, thromboembolism and anticoagulant-related bleeding continue to account for 75% of all complications after mechanical valve replacement. Occurring most commonly within six months after implantation, these complications can adversely affect mortality and quality of life. Furthermore, the threat of their occurrence creates a psychological burden for each patient with a mechanical valve. The need for life-long anticoagulation in patients with mechanical valves is not in dispute, and the perioperative management of anticoagulation during non-cardiac surgery has been reviewed extensively. However, the approach to early postoperative anticoagulation after mechanical valve implantation is still a matter of debate. The optimal intensity and timing of anticoagulation to prevent early thromboembolism after valve replacement surgery without postoperative bleeding complications is unknown. Hence, many anticoagulation protocols have been proposed, but a lack of consensus remains. The objectives of this study were (1) to reexamine the pathogenesis of thrombus formation and the need for anticoagulation; (2) to critically review the literature on early postoperative anticoagulation strategies; and (3) provide an estimate of the incidence of bleeding and thromboembolism for each approach to early postoperative anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427905     DOI: 10.1016/j.athoracsur.2005.07.023

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  20 in total

1.  Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding.

Authors:  Prashanth Panduranga; Mohammed Al-Mukhaini; Muhanna Al-Muslahi; Mohammed A Haque; Abdullah Shehab
Journal:  World J Cardiol       Date:  2012-03-26

2.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Three-dimensional extent of flow stagnation in transcatheter heart valves.

Authors:  Vrishank Raghav; Chris Clifford; Prem Midha; Ikechukwu Okafor; Brian Thurow; Ajit Yoganathan
Journal:  J R Soc Interface       Date:  2019-05-31       Impact factor: 4.118

4.  Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery.

Authors:  Boxia Li; Ruisheng Liu; Chengqi Wang; Changan Ren; Shiming Zhang; Fan Zhang; Jianping Zhang; Shidong Liu; Yuhui Wei; Wenjing Liu; Bing Song; Xinan Wu
Journal:  Eur J Clin Pharmacol       Date:  2019-08-23       Impact factor: 2.953

5.  A mechanical heart valve is the best choice.

Authors:  Iqbal H Jaffer; Richard P Whitlock
Journal:  Heart Asia       Date:  2016-04-28

6.  Stentless xenograft implantation in aortic position in a 7-year-old girl.

Authors:  Sadik Sharef; Ryan Coleman; Shannon Rivenes; Ivan Wilmot; Carolyn Altman; Ramiro Madden-Fuentes; Jorge Salazar
Journal:  Tex Heart Inst J       Date:  2010

7.  Freedom from thromboembolism despite prolonged inadequate anticoagulation.

Authors:  Frank Edwin; Mark Mawutor Tettey; Ernest Aniteye; Lawrence Sereboe; Martin Tamatey; Kow Entsua-Mensah; David Kotei; Kwabena Frimpong-Boateng
Journal:  BMJ Case Rep       Date:  2009-09-15

8.  Low molecular weight heparin in surgical valve procedures: When and how much for an optimal prophylaxis?

Authors:  Katarzyna Czerwińska-Jelonkiewicz; Marek Cisowski; Andrzej Bochenek; Piotr Buszman; Krzysztof Milewski; Piotr Kunik; Magdalena Mularska; Krzysztof Kocot; Piotr Politowski; Jakub Brączkowski; Agata Trznadel; Michael S Aboodi; Paweł Buszman
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

9.  Successful treatment of severe mechanical mitral valve thrombosis with tissue plasminogen activator in a 7-month-old infant.

Authors:  Eva W Cheung; Linda Aponte-Patel; Emile A Bacha; Rakesh K Singh; Erika Berman Rosenzweig; Anita I Sen
Journal:  Pediatr Cardiol       Date:  2012-08-12       Impact factor: 1.655

Review 10.  Role of novel anticoagulants for patients with mechanical heart valves.

Authors:  Peter Forsberg; Maria T DeSancho
Journal:  Curr Atheroscler Rep       Date:  2014-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.